Literature DB >> 12960967

Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation.

Adriana Balduzzi, Vincenzo Rossi, Lilia Corral, Sonia Bonanomi, Daniela Longoni, Attilio Rovelli, Valentino Conter, Andrea Biondi, Cornelio Uderzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12960967     DOI： 10.1038/sj.leu.2403134

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.

Authors:  Patrice Chevallier; Beatrice Mahe; Richard Garand; Pascaline Talmant; Jean-Luc Harousseau; Jacques Delaunay
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

2.  Gemtuzumab ozogamicin-induced long-term remission in a woman with acute myelomonocytic leukemia and bone marrow relapse following allogeneic transplantation.

Authors:  Masahiko Sumi; Naoaki Ichikawa; Kentaro Nasu; Ikuo Shimizu; Toshimitsu Ueki; Mayumi Ueno; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2009-11-11       Impact factor: 2.490

Review 3.  Antibody therapy for pediatric leukemia.

Authors:  Aditi Vedi; David S Ziegler
Journal:  Front Oncol       Date:  2014-04-21       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.